MetaStat Inc.
Stock Exchange Other OTC
EPS
$0.6
Market Cap
$399.64 K
Shares Outstanding
5.88 M
Public Float
5.76 M

Profile

Address
27 Drydock Avenue
Boston Massachusetts 02210
United States
Employees -
Website http://www.metastat.com
Updated 07/08/2019
MetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes MetaSite Breast and MenaCalc platforms. The MetaSite Breast test measures the process of systemic metastasis and is intended for early stage breast cancer patients.

Financials

View All

Douglas A. Hamilton
President, Chief Executive Officer, CFO & Director
Jerome B. Zeldis
Chairman